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Abstract: The specific component responsible and the mechanistic pathway for increased 
human morbidity and mortality after cigarette smoking are yet to be delineated. We propose that 
1) injury and disease following cigarette smoking are associated with exposure to and retention 
of particles produced during smoking and 2) the biological effects of particles associated with 
cigarette smoking share a single mechanism of injury with all particles. Smoking one cigarette 
exposes the human respiratory tract to between 15,000 and 40,000 µg particulate matter; this 
is a carbonaceous product of an incomplete combustion. There are numerous human exposures 
to other particles, and these vary widely in composition, absolute magnitude, and size of the 
particle. Individuals exposed to all these particles share a common clinical presentation with 
a loss of pulmonary function, increased bronchial hyperresponsiveness, pathologic changes of 
emphysema and fibrosis, and comorbidities, including cardiovascular disease, cerebrovascular 
disease, peripheral vascular disease, and cancers. Mechanistically, all particle exposures pro-
duce an oxidative stress, which is associated with a series of reactions, including an activation 
of kinase cascades and transcription factors, release of inflammatory mediators, and apoptosis. 
If disease associated with cigarette smoking is recognized to be particle related, then certain aspects 
of the clinical presentation can be predicted; this would include worsening of pulmonary function 
and progression of pathological changes and comorbidity (eg, emphysema and carcinogenesis) 
after smoking cessation since the particle is retained in the lung and the exposure continues.
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Introduction
Smoking is one of the ten greatest contributors to global death and disease1 and is the 
single most important risk factor for chronic obstructive pulmonary disease (COPD), 
  cardiovascular disease, cerebrovascular disease, peripheral vascular disease, and   numerous 
cancers in the United States.2 The specific component responsible and the mechanistic 
pathway for increased human morbidity and mortality after cigarette smoking are yet to 
be delineated. Cigarette smoking is a particle-related exposure. While obvious disparities 
exist between cigarette smoking and exposures to other particles, there are many similari-
ties in the physiologic changes, pathology, and comorbidities. We propose that 1) injury 
and disease following cigarette smoking are associated with exposure and retention of 
particles produced during smoking and 2) the biological effects of particles associated 
with cigarette smoking share a single mechanism of injury with all particles.
Human exposures to particles
In a burning cigarette, temperatures in the combustion zone (800°C–950°C) result in a 
complete pyrolysis of tobacco.3 Immediately downstream, a rapid drop in temperature International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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(to 200°C–600°C) and a lack of oxygen allow for incomplete 
combustion of tobacco. Subsequently, a complex aerosol is 
generated during smoking, which includes condensed liquid 
droplets (the particulate fraction or tar) suspended in a mix-
ture of volatile and semivolatile compounds and combustion 
gases (the gas fraction). Smoking one cigarette exposes the 
human respiratory tract to between 15,000 and 40,000 µg 
particulate matter (PM).4 The composition of cigarette 
smoke PM is comparable to that of other particles gener-
ated through an incomplete combustion of carbonaceous 
material, and this includes a heterogeneous, amorphous, 
organic material.5–7
Human exposures to other particles vary in composi-
tion, absolute magnitude, and size of the particle (Table 1). 
After cigarette smoking, the burning of biomass (defined as 
some combination of wood, charcoal, agricultural residues, 
and animal dung) is likely to be the PM source of greatest 
significance internationally. More than 2 billion people in the 
world use biomass as their main source of energy for domestic 
heating and cooking, and 80% of total global exposure to PM 
occurs indoors in developing nations.
Particle-related lung injury
Individuals exposed to all these different particles share a 
common clinical presentation. Depending on the compo-
sition, magnitude, and duration of the particle exposure, 
there can be 1) loss of pulmonary function, 2) increased 
bronchial hyperresponsiveness, 3) pathological alterations 
of emphysema and fibrosis, 4) hemorheological changes, 
and 5) comorbidities, including cardiovascular disease, 
cerebrovascular disease, peripheral vascular disease, and 
cancers.
Loss of pulmonary function
Smoking cigarettes decreases all indices of lung function but 
particularly affects flows.8 On an average,   moderate-to-heavy 
male smokers have a 15 mL/year larger decline in forced expi-
ratory volume in 1 sec relative to nonsmokers.9 The greater 
the number of cigarettes smoked (ie, pack years), the higher 
the rate of decline in lung function.9 The extreme loss of 
function after cigarette smoking can result in COPD, a major 
cause of morbidity and mortality throughout the world. 
COPD, a disease state characterized by airflow limitation that 
is not fully reversible, is currently the fourth leading cause of 
death in the world, and further increase in the prevalence and 
mortality of the disease is predicted in the coming decades. 
Internationally, the prevalence of COPD is highest in coun-
tries where cigarette smoking is common.10
Other particle exposures are similarly associated with 
loss in pulmonary function and COPD. Environmental 
tobacco smoke (ETS),11–13 woodstove emissions,14 use of 
gas stoves, burning of biomass other than wood,15–19 and air 
pollution particles20 decrease indices of pulmonary   function. 
COPD has been observed among nonsmoking individu-
als exposed to both open fires/burning of biomass21,22 
and occupational dusts, including coal and mineral oxide 
particles.23
Bronchial hyperreactivity
Cigarette smoking24,25 and ETS exposure26,27 elevate bron-
chial hyperresponsiveness. There is a dose-dependent 
relationship between the number of cigarettes smoked and 
the degree of hyperresponsiveness.28 Particles other than 
those in cigarette smoke similarly affect bronchial hyper-
responsiveness. Diesel exposure has been associated with 
Table 1 Particle-related exposures associated with human lung injury
Particle source Composition of particle Magnitude of exposure Particle size
Cigarette smoking Carbonaceous combustion product 15,000–40,000 µg/cigarette Fine and ultrafine
Environmental tobacco  
smoke137–139
Carbonaceous combustion product #1000 µg/m3 Fine and ultrafine
Forest fires140 Carbonaceous combustion product #1000 µg/m3 but variable Fine and ultrafine
Wood-burning stove141–143 Carbonaceous combustion product #1200 µg/m3 Fine and ultrafine
Gas stove144,145 Carbonaceous combustion product #1380 µg/m3 Fine and ultrafine
Diesel exhaust146,147 Carbonaceous combustion product #10 µg/m3 in ambient air
,1000 µg/m3 in mines
Ultrafine
Burning of biomass145,148–150 Carbonaceous combustion product #10,000 µg/m3 but variable Coarse, fine, and ultrafine
Air pollution151 Variable #50 µg/m3 nationally
#500 µg/m3 internationally
Coarse, fine, and ultrafine
Coal mining Carbonaceous #2000 µg/m3 nationally Coarse and fine
Mining of minerals Inorganic (eg, silica and silicates) #1000 µg/m3 for silica
#5000 µg/m3 for nuisance dust
Coarse and fineInternational Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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comparable changes in bronchial hyperresponsiveness.29 
The response to methacholine also increases following 
  exposure of firefighters.30–32 Occupational exposure to dust 
can increase airway   reactivity, including both coal dust24,33 
and mineral oxide.34 This   relationship between particle expo-
sure and bronchial responsiveness is widely recognized, and 
a challenge inhalation with particles has been proposed as 
an alternative to methacholine testing.35,36
Lung histopathology
Cigarette smoking has been associated with an acute influx 
of neutrophils into the lower respiratory tract.37 This is 
  comparable to other particle-associated injuries,   including 
exposures to ambient air pollution particles and diesel 
exhaust.38,39
The two chronic pathologic processes noted on micro-
scopic inspection of the lungs from individuals exposed to 
particles are emphysema and fibrosis. Emphysema is most 
frequently caused by cigarette smoking, but is also observed 
after other particle exposures, including burning of biomass,40 
mineral oxide,23,41,42 and coal dust.43–47 Histologically, 
emphysema, following all these exposures, including ciga-
rette smoking, occurs immediately adjacent to the retained 
particle.48–51 In one animal study, the emphysema severity 
was dependent on the concentration of cigarette smoke total 
PM.52 Mucous cell hyperplasia, hypertrophy, and inflamma-
tory cell infiltrates were present in the epithelium of large 
airways of cigarette smoke–exposed mouse lungs. Further, 
allowing the mice to recover from cigarette smoke exposure 
was not associated with reversal of emphysema, and cigarette 
smoke–induced pulmonary inflammation also persisted.
Fibrosis can also be observed following exposures 
to numerous different particle exposures. Increased col-
lagen is frequently observed in the lungs of cigarette 
smokers,53–55 and irregular opacities reflecting this fibrosis 
can be observed on their chest X-rays comparable to those 
in pneumoconioses.23,56–58 Collagen deposition and fibrosis 
in the human lung have been described following exposure 
to ambient air pollution particles,59 environmental exposure 
to crustal particles (eg, windstorms),60,61 and inhalation 
of emission source particles.62 This fibrogenic property of 
particles is exploited therapeutically with the instillation of 
gram quantities of a mineral oxide (ie, talc) particle into the 
pleural space to provide sclerosis.63
Hemorheological changes
Cigarette smoking leads to a rise in hematocrit, increased 
total white cell count, and modified leukocyte function. 
Elevations in the plasma concentrations of fibrinogen are also 
associated with smoking;64,65 a dose–response relationship 
between smoking and the plasma fibrinogen level has been 
described.66 Following smoking cessation, plasma fibrinogen 
will drop immediately but takes 5 years to return to normal.67 
Abnormalities in platelet function can similarly occur with 
smoking with an increase in platelet aggregation occurring 
as rapidly as 10 min after smoking a cigarette.68,69
Other particle exposures elicit comparable changes in 
blood components. ETS exposure can be associated with 
platelet aggregation.70 Ambient air pollution particles effect 
several changes in the peripheral blood, including decreases 
in red cell number,71 elevations in white blood cell counts,71 
and increases in C-reactive protein,71 fibrinogen,38,71,72 and 
blood viscosity;71,73 the last two potentially contribute to 
the association of ambient PM with thrombotic events.74 
Other particles have comparable effects on hemorheologic 
indices.75,76
Comorbidities
Cigarette smoking is the major risk factor in many industri-
alized societies for cardiovascular disease and increases the 
prevalence of coronary artery disease,77,78 cerebrovascular 
disease,79 and peripheral vascular disease.80 Convincing 
evidence also links ETS exposure to both cardiac morbid-
ity and mortality and peripheral vascular disease.81 Forest 
firefighting82 and diesel exhaust83 similarly elevate the rate 
of cardiovascular disease. The inhalation of ambient air 
pollution PM can increase the incidence of myocardial 
infarction,84 hospital admission for cardiovascular diseases,85 
and the rate of arrhythmias.86 Finally, exposures to mineral 
oxide and coal dust can be associated with an increased risk 
for cardiovascular disease.87,88
There are elevations in the incidence of cancer with 
either cigarette smoking89 or exposure to ETS.90,91 There is 
also concern for an induction of neoplasms by other particle-
associated injuries, including that induced by diesel exhaust,92 
forest fire fighting,93 burning of biomass other than wood,94 
the use of wood-burning stoves,95 and occupational exposures 
to silica.96 Recent investigation has similarly suggested a 
carcinogenicity of ambient air pollution particles.97
Mechanism of injury following  
particle exposures
Shared characteristics of the physiologic response,   pathology, 
and comorbidities between PM included in cigarette smoke 
and other particles suggest a common mechanism of biologi-
cal effect. All particle exposures produce an oxidative stress. International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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A generation of reactive oxygen species results either 
directly from some component of the particle supporting an 
  inappropriate electron transfer or from an interaction of the 
PM with cell proteins (eg, electron transport complexes in 
the mitochondria). Oxidative stress is accepted as the initial 
step in the biological effect after cigarette smoking98 and all 
other particle exposures.99
Oxidants generated by particle exposures can cause 
sequential changes culminating in tissue injury (Figure 1). 
Among the early cell targets of oxidative stress are kinase 
cascades. Mitogen-activated protein (MAP) kinases (p38 
MAP kinase family, the extracellular signal-regulated kinase 
(ERK) family, and the c-Jun NH2-terminal kinase (JNK) 
family) are widely expressed serine–threonine kinases 
which mediate regulatory signals in the cell. The activation 
of specific MAP kinase signaling cascades is required for 
induction of various cellular responses, including phospho-
rylation of transcription factors (eg, NF-E2-related factor 2 
(Nrf2), nuclear transcription factor-kappaB (NF-kB), and 
activator protein-1 (AP-1)) and transcriptional regulation, 
nuclear chromatin remodeling and gene induction, cytokine 
production, as well as regulation of apoptosis and cell-cycle 
progression.100 Exposure to cigarette smoke leads to activa-
tion of MAP kinases and pro-inflammatory transcription 
factors (Nrf2, NF-kB, and AP-1), and this is considered to 
be a key mechanistic event leading to cell   differentiation, 
release of inflammatory mediators, and inflammatory 
injury in the lungs.101–107 Regarding one transcription factor, 
macrophage exposure to cigarette smoke induced nuclear 
accumulation of Nrf2 and activated the transcription of 
Nrf2 target genes.108 This suggests that Nrf2 in macrophages 
may participate in the human response to cigarette smoke 
exposure. Basal Nrf2 mRNA levels and Nrf2 target gene 
expressions were significantly lower in alveolar macrophages 
obtained from 1) older current smokers relative to and from 
lifelong nonsmokers and 2) patients with COPD relative to 
nonsmokers and former smokers without COPD. The same 
cascade of reactions (Figure 1) appears to also participate in 
cell apoptosis after cigarette smoke exposure.109–114
The pathway of inflammation and apoptosis following 
exposure to other particles is indistinguishable from that 
after cigarette smoke exposure (Figure 1). Numerous PM 
exposures activate the same kinases and pro-inflammatory 
transcription factors observed with cigarette smoke.115–118 
Comparable to cigarette smoke, the same particles sub-
sequently affect a release of inflammatory and apoptotic 
mediators.119–124
Activation of kinase cascades and transcription factors 
following particle exposure can also effect an inflammatory 
and apoptotic response in extrapulmonary sites. Mainstream 
cigarette smoke exposure is associated with activation of 
p38 and ERK1/2 MAP kinases.125 Ambient air pollution 
particles similarly induce reactive oxygen species generation 
in human endothelial cells, resulting in cell barrier disrup-
tion via p38 MAP kinase–dependent pathways.126,127 These 
findings support one common pathway for biological effect 
of all particles in all tissues.
Conclusions
Particle-related biological effects continue to be defined. 
Investigation has demonstrated comparable effects of ciga-
rette smoke and other particle-related exposures. A shared 
mechanism of biological effect between cigarette smoking 
and other particle exposures would further understanding of 
human disease. If disease associated with cigarette smoking 
is recognized to be particle related, then certain aspects of the 
clinical presentation can be predicted. For example, worsen-
ing of pulmonary function and progression of pathological 
changes after smoking cessation is predicted since the par-
ticle continues to be sequestered in the lung, and biological 
effect corresponds to such persistence.128–130 Finally, a shared 
pathway of biological effect predicts that genetic predisposi-
tion to one particle-related injury may also influence another 
(eg, polymorphisms in glutathione transferase will function 
as a risk factor in injury after cigarette smoking and exposure 
Triggering of cell 
Oxidative stress
Particle exposure
signaling pathways 
(eg, MAP Kinases)
Cancer Emphysema
and fibrosis
Vascular disease
Apoptosis Inflammation
Mediator synthesis
Transcription factor 
activation
(eg, AP-1, NF-κB, 
and nrf-2) 
Figure  1  Mechanism  of  biological  effect  following  particle  exposure.  Particles 
effect an oxidative stress, which prompts a series of reactions by the host, including 
activation  of  cell  signaling  pathways  and  transcription  factors  and  inflammatory 
mediator release. This culminates in inflammation and apoptosis which, if prolonged 
or misregulated, can produce emphysema, fibrosis, vascular disease, and cancer.
Abbreviations: MAP, mitogen-activated protein; AP-1, activator protein-1; NF-kB, 
nuclear transcription factor-kappaB; Nrf2, NF-E2-related factor 2.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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to air pollution particles).131,132 Those genetic factors which 
are demonstrated to participate in lung injury after either 
cigarette smoking or other specific disease following particle 
exposure should be examined for a contribution in any of the 
particle-related diseases.133–136
Disclaimer
This report has been reviewed by the National Health 
and Environmental Effects Research Laboratory, United 
States Environmental Protection Agency, and approved for 
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